Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
This supplement features stories of success and challenges in the hard-fought and expensive race to increase survival rates. But it’s not all good news - improved treatments may still be out of reach in the countries where 70% of global cancer deaths occur.
The da Vinci robotic system has become the ubiquitous method for prostate removal, but its cost and long-term outcomes for patients are raising questions.
The search for disease mechanisms and treatments is one of the biggest collaborative efforts in science. These researchers are significant contributors.
Integrating basic and clinical research, a new cancer institute established at Peking University welcomes cross-disciplinary researchers from around the world.
A stronger and more precise form of radiotherapy is poised to take a leading role in mainstream cancer therapy. It also provides options for those with previously untreatable cancers.
By integrating cancer research, treatment, prevention, and education, a specialized hospital in Tianjin is fulfilling its commitment to provide patients with the best care and medicine.
Fundamental and translational research at the China Medical University in Taiwan reveals crucial insights for cancer mechanisms, informing the development of precision medicine.
Emerging smart tools are helping prevent disease onset and progression. The medical informatics hub at Nagoya University is training specialists that will drive life-saving developments.
By harnessing genomic data and a multidisciplinary approach to cancer care, Asan Medical Center is forging ahead with individually tailored treatments, and it’s attracting international patients.
A conversation with PETER SHIELDS, MD, deputy director at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James)
The Janssen Pharmaceutical Companies of Johnson & Johnson and the Lung Cancer Initiative at Johnson & Johnson are taking on the world’s most deadly cancer.
A young laboratory in Shenzhen aspires to be a world-class hub for biomedical and life sciences research to prevent and find effective solutions for major diseases, including cancer.